Arjun Dhwoj Bamjan (목포대학교)님 | 한빛사연구자 > 한빛사

목포대학교

최종업데이트 2024.12.31.

Dual-transporter-targeted oral semaglutide nanomicelles enable enhanced intestinal absorption and metabolic reprogramming in obesity and diabetes
- J. Control. Release, Available online 24 August 2026, 115297 | https://doi.org/10.1016/j.jconrel.2026.115297
- 2026-08
- 의약학
- 한빛사논문
An oral liraglutide nanomicelle formulation conferring reduced insulin-resistance and long-term hypoglycemic and lipid metabolic benefits
- J. Control. Release, Dec 26 2024, 378 S0168-3659(24)00891-5 | https://doi.org/10.1016/j.jconrel.2024.12.039
- 2024-12
- 의약학
- 한빛사논문

연구자 ID

저자논문